Cat. No. | Product name | CAS No. |
DCC4164 |
Piloquinone
Natural activator of cryptic biosynthetic gene clusters (BGC), also acting as a potent inhibitor of monoamine oxidase B |
25414-26-0 |
DCC4165 |
Pim-in-14j
Potent, highly selective, and orally bioavailable inhibitor of PIM-1 kinases |
1036380-87-6 |
DCC4166 |
Pim-in-a47
Novel potent PIM inhibitor |
|
DCC4167 |
Pinoxepin Hydrochloride
Antipsychotic agent |
14008-46-9 |
DCC4168 |
Pip4k-in-a131
Inhibitor of PIP 4 Ks, efficiently killing transformed BJ cells, but not normal counterparts, displaying a strong selective lethality against Ras-activated or Ras-transformed cells |
2055405-95-1 |
DCC4169 |
Pipequaline Hydrochloride
Partial agonist of benzodiazepine receptors |
80221-58-5 |
DCC4170 |
Piperacetazine
Antipsychotic prodrug, most notably used for schizophrenia |
3819-00-9 |
DCC4171 |
Piperazinomycin
Antifungal antibiotic, showing inhibitory activity against fungi and yeasts, especially against Trichophyton |
83858-82-6 |
DCC4172 |
Piperidol B2
Novel potent in vitro and in vivo antifungal agent against azole-resistant Candida albicans |
|
DCC4173 |
Piperneolignan A
Natural nitric oxide (NO) production inhibitor |
|
DCC4174 |
Piroxicam-ß-cyclodextrin
NSAID with better gastrointestinal (GI) tolerability |
121696-62-6 |
DCC4175 |
Pitofenone
Inhibitor of the acetylcholinesterase activity from bovine erythrocytes and electric eel |
54063-52-4 |
DCC4176 |
Pixantrone
Inhibitor of topoisomerase II, intercalating into DNA and inducing topoisomerase II-mediated DNA strand crosslinks, resulting in inhibition of DNA replication and tumor cell cytotoxicity |
144510-96-3 |
DCC4177 |
Pk5196
Potent ligand to target the Y220C pocket, stabilizing Y220C |
|
DCC4178 |
Pkc-iota-in-19
Novel Protein Kinase C-iota (PKC-ι) Inhibitor, Binding Post-kinase Domain Residues |
|
DCC4179 |
Pkcθ-in-41
Novel selective inhibitor of protein kinase Cθ (PKCθ) |
|
DCC4180 |
Pkm2-in-8
Novel highly potent and selective PKM2 inhibitor, blocking PKM2 mitochondrial translocation under nutritional stress and inhibits tumor growth in vivo |
|
DCC4181 |
Pks21272
Novel potent and specific β5i inhibitor |
|
DCC4182 |
Pkumdl-ltq-301
Potent inhibitor of HipA toxin, inhibiting E. coli persistence |
728886-01-9 |
DCC4183 |
Pladienolide B
mRNA splicing inhibitor |
445493-23-2 |
DCC4184 |
Plafibride
Antilipidemic and antiplatelet agent |
63394-05-8 |
DCC4185 |
Plap Inhibitor 16
Novel Potent and Specific Inhibitor of Placental Alkaline Phosphatase (PLAP; IC 50 = 32 nM), Targeting Tumor of the Female Reproductive Tract |
|
DCC4186 |
Plasiatine
Novel Potent Activator of the Nonreceptor Protein Tyrosine Phosphatase Shp2 |
|
DCC4187 |
Plaunotol
Gastroprotective agent, increasing the prostaglandin production in the gastric mucosa and accelerates ulcer healing |
64218-02-6 |
DCC4188 |
Plazomicin
Broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis |
1154757-24-0 |
DCC4189 |
Plc Inhibitor 3017
Novel inhibitor of phospholipase C (PLC) isozyme |
|
DCC4190 |
pl-dhn
Novel enhancer of Reactive Oxygen Species (ROS), depleting glutathione levels in analogy to piperlongumine but with reduced cell death |
1415152-77-0 |
DCC4191 |
Plectranthoic Acid
Novel activator of AMPK, inducing apoptotic death in prostate cancer cells |
82373-96-4 |
DCC4192 |
Plhspt
Plk1 PBD-specific phosphopeptide inhibitor, effectively inhibiting mitotic progression and cell proliferation |
|
DCC4193 |
Plk1 Pbd-in-143
Novel Inhibitor of the Polo-Box Domain of Polo-like Kinase 1 (Plk1 PBD) |
923783-24-8 |
DCC4194 |
Plk1-in-7k
Novel polo-like kinase 1 (PLK1) inhibitor |
|
DCC4195 |
Plx647(ome)
Slightly less potent inhibitor of FMS than PLX647 but has better aqueous solubility |
923562-22-5 |
DCC4196 |
Pm00104
Potent anticancer tetrahydroisoquinoline alkaloid, being able to form a covalent bond with the amino group of a guanine in selected triplets of DNA duplexes and eventually give rise to double-strand breaks |
308359-57-1 |
DCC4197 |
Pmed-1
Novel inhibitor of β-catenin signaling, significantly reduced β-catenin activity in hepatoblastoma and several HCC cells |
|
DCC4198 |
Pmmb-317
Novel potent irriversible dual inhibitor of tubulin and epidermal growth factor receptor (EGFR), inducing the apoptosis of A549 cells in a dose- and time-dependent manner, along with decrease in mitochondrial membrane potential (MMP), production of ROS an |
|
DCC4199 |
Pmpmease-in L-23
Novel inhibitor of prenylated methylated protein methyl esterase (PMPMEase), a key enzyme in the reversible methylation/demethylation step in the protein prenylation pathway |
1190196-76-9 |
DCC4200 |
Pmpmease-in L-28
Novel inhibitor of prenylated methylated protein methyl esterase (PMPMEase), a key enzyme in the reversible methylation/demethylation step in the protein prenylation pathway |
1190196-77-0 |
DCC4201 |
P-mppf Dihydrochloride
Selective 5-HT1A serotonin receptor antagonist |
223699-41-0 |
DCC4202 |
P-nitro-pifithrin-α
Cell-permeable analog of pifithrin-α, potently blocking p53-mediated expression of p21/WAF1 and apoptosis |
389850-21-9 |
DCC4203 |
Pnr-4-20
Novel G Protein-Biased Cannabinoid 1 (CB1) Receptor Agonist |
|
DCC4204 |
Pnu-292137
Potent inhibitor of CDK2/cyclin A |
326823-27-2 |
DCC4205 |
Pnu-69176e
Allosteric modulator of 5-HT(2C)R with no intrinsic agonist activity |
625120-71-0 |
DCC4206 |
Pnz-tmp
The first small-molecule approach capable of detecting and controlling engineered cell-cell outputs |
|
DCC4207 |
Podoverine A
Novel microtubule destabilizing natural product from the Podophyllum species |
107882-43-9 |
DCC4208 |
Pol I Inhibitor T5
Novel RNA polymerase I inhibitor, targeting ribosomal DNA G-quadruplexes, potently and selectively inhibiting cell growth by high-affinity binding to G4s in ribosomal DNA, impairing RNA polymerase I (Pol I) elongation, inducing a rapid inhibition of Pol I |
|
DCC4209 |
Pol7001
Novel macrocycle antibiotic with selective and potent activity against P. aeruginosa |
944152-19-6 |
DCC4210 |
Poloppin-ii
Novel modulator of protein-protein interactions of the mitotic polo-like kinases, targeting KRAS mutant xenografts, indicate avenues, acting synergistically with Crizotinib, an inhibitor of the c-MET receptor, against mutant KRAS-expressing cancer cells |
|
DCC4211 |
Poloxipan
Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis |
1239513-63-3 |
DCC4212 |
Poly(ethyleneimine) Solution
Used for the transfection of a broad variety of cell lines; Antimicrobial; Novel binding agent of diffusive gradients in thin-films (DGT) technique (PEI-DGT) |
9002-98-6 |
DCC4213 |
polygonatone D
Novel activator of Adenosine monophosphate (AMP)-activated protein kinase (AMPK) |
1432632-42-2 |
DCC4214 |
Polymyxin
Antibiotic as a last-line therapy to treat infections caused by these life-threatening 'superbugs' |
1406-11-7 |
DCC4215 |
polyphenol 13b
Novel pan-inhibitor of KCa3.1/KCa2 channels |
1222380-73-5 |
DCC4216 |
Pom2-c-hmbp
Potent Activator of Vγ9Vδ2 T-Lymphocytes; HMBPP ananlog prodrug |
|
DCC4217 |
Ponfibrate
Hypobetalipoproteinemic and Lipid decreasing agent |
53341-49-4 |
DCC4218 |
Poziotinib Hydrochloride
Novel pan-human EGF receptor (HER) inhibitor |
1429757-68-5 |
DCC4219 |
Ppa250
Novel iNOS homodimerization inhibitor |
|
DCC4220 |
Pparalpha/delta-in-11
The first reported PPARα/δ dual antagonist |
|
DCC4221 |
Pparalpha/gamma Agonist N15
Novel dual PPARα/γ agonist, ameliorating insulin resistance and gluconeogenesis in vivo and vitro |
1821380-90-8 |
DCC4222 |
Ppi Inhibitor-i
Novel inhibitor of protein-protein interaction (PPI), blocking #212121; font-family: BlinkMacSystemFont, -apple-system, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", sans-serif; font-size: 14px; font-style: no |
|
DCC4223 |
pp-ii-a03
Novel insulin mimetic |
1136374-51-0 |
DCC4224 |
Ppi-in-3344
Novel pan-RAS-effector PPI inhibitor |
|
DCC4225 |
Ppk1-in-17
Novel PPK1 inhibitor, preventing UTI effectively through the disruption of the PPK1 function |
|
DCC4226 |
Ppk1-in-8
Novel PPK1 inhibitor, preventing UTI effectively through the disruption of the PPK1 function |
1571-87-5 |
DCC4227 |
pppone
Potent and selective antagonist of melanocortin-4 receptor (MC4R) |
89011-87-0 |
DCC4228 |
Ppq-581
Novel anti-influenza agent, interrupting the crucial RNP trafficking, resulting in influenza replication inhibition, preventing virus-induced cytopathic effects |
950381-32-5 |
DCC4229 |
Ppt (water-heme Modulator)
Novel Modulator of Water-Heme Interactions in Low-Spin P450 Complexes of CYP2C9d and CYP125A1 |
1529779-90-5 |
DCC4230 |
Ppxy Budding Inhibitor 4
Novel inhibitor of budding of mVP40 and eVP40 VLPs, blocking mVP40-795 Nedd4 protein-protein interaction. |
956571-77-0 |
DCC4231 |
Ppxy Budding Inhibitor 5
Specific blocker of the MARV VP40 PPxY-host Nedd4 interaction and subsequent PPxY-dependent egress of MARV VP40 VLPs. |
1797967-45-3 |
DCC4232 |
Pqa-11
Novel potent neuroprotectant, inhibiting glutamate-induced cell death, caspase-3 activation, and amyloid β1-42-induced cell death, also suppressing mitogen-activated protein kinase kinase 4 (MKK4) and c-jun N-terminal kinase (JNK) signaling activated by n |
|
DCC4233 |
Pqc-078
Novel inhibitor of IMPDH enzyme |
|
DCC4234 |
Pqq-tme
Novel human double minute 2 (HDM2) inhibitor |
74447-88-4 |
DCC4235 |
Pqsr Antagonist M64
Quorum sensing modulator as a PqsR antagonist |
|
DCC4236 |
Pradigastat
Featured
Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects. |
956136-95-1 |
DCC4237 |
Pravadoline Maleate
Inhibitor of prostaglandin (PG) synthesis |
92623-84-2 |
DCC4238 |
Prazosin
Inverse agonist at alpha-1 adrenergic receptors |
19216-56-9 |
DCC4239 |
Prexasertib Monolactate Monohydrate
Novel inhibitor of checkpoint kinase 1 (CHK1) |
2100300-72-7 |
DCC4240 |
Pridopidine Hydrochloride
Inducer of Functional Neurorestoration Via the Sigma-1 Receptor |
882737-42-0 |
DCC4241 |
prmt3 Inhibitor 1
Allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3) |
1340875-03-7 |
DCC4242 |
prmt3 Inhibitor 14u
Potent and selective inhibitor of protein arginine methyltransferase 3 (PRMT3) |
|
DCC4243 |
Prmt4-in-1
Novel potent and selective inhibitor of PRMT4 (also known as CARM1) |
|
DCC4244 |
Prmt5-in-4b14
Novel potent PRMT5 inhibitor, exhibiting potent anti-proliferative activity against a panel of leukemia and lymphoma cells |
|
DCC4245 |
Prmt5-in-c17
Featured
Novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor |
330951-01-4 |
DCC4246 |
Prmts Inhibitor A36
Potent inhibitor of protein arginine methyltransferases (PRMTs) |
318263-94-4 |
DCC4247 |
Prmts Inhibitor A9
Potent inhibitor of protein arginine methyltransferases (PRMTs) |
380652-58-4 |
DCC4248 |
Prn1008
Novel, Reversible Covalent BTK Inhibitor for Rheumatoid Arthritis |
1575596-77-8 |
DCC4249 |
Prn1126
Novel reversible covalent selective LMP7 inhibitor |
|
DCC4250 |
pr-nhp5g
Antagonist at the NR1/NR2A subtype but an agonist at the NR1/NR2D subtype |
1040283-99-5 |
DCC4251 |
Probimane
Potent inhibitor of tumor metastasis, inhibiting calmodulin, sialic acid, lipoperoxidation, fibrinogen, cell-movement and the cell-cycle arrest |
108093-90-9 |
DCC4252 |
Procaspase-8 Inhibitor 63-r
Novel selective procaspase-8 (Pro-C8) Inhibitor covalently binding the zymogen, or inactive precursor (pro-form), of caspase-8, but not other caspases |
|
DCC4253 |
Pro-nbdhex
Prodrug of NBDHEX, selectively inhibiting glutathione transferase (GST P1-1) with better water solubility, and more potent anticancer activities |
|
DCC4254 |
Protac 14a
Novel potent cereblon degrader with DC50 of 200 nM, and 64% protein degradation, as quantified by western blot |
2358775-70-7 |
DCC4256 |
Protac Cp17
Novel highly potent degrader against EGFRL858R/T790M and EGFRdel19, reaching the lowest DC 50 values among all reported EGFR-targeting PROTACs |
|
DCC4257 |
Protac D9a-2
Novel SLC-targeting chimeric degrader, targeting SLC9A1 and other SLC9 family members, effectively impairing pH homeostasis and differentially killing cancer cell lines |
|
DCC4258 |
Protac Degrader Pp-c8
Novel noncovalent CDK12/13 dual inhibitor, inducing potent and selective CDK12-CycK degradation without affecting CDK13, suppressing DDR-associated genes and induced synthetic lethality with Olaparib |
|
DCC4259 |
Protac Hl-8
Novel PI3K degrader, showing a significant and complete degradation effect on PI3K kinase at a concentration of 10 μM within 8 h |
|
DCC4260 |
Protac Nr-7h
Novel potent and selective p38α and p38β degrader |
|
DCC4261 |
Protac P22a
Novel degrader of HMGCR protein, potently blocking cholesterol biosynthesis with less compensatory upregulation of HMGCR |
|
DCC4262 |
Protac P3
Novel potent epidermal growth factor receptor (EGFR) degrader, inducing EGFRdel19 and EGFRL858R/T790M degradation with DC50 values of 0.51 and 126 nM, showing potent anti-proliferative activity against HCC827 and H1975 cell lines with IC50 values of 0.83 |
|
DCC4263 |
Protac(h-pgds)-1
Novel potent degrader of H-PGDS protein via the ubiquitin-proteasome system and in the suppression of prostaglandin D2 (PGD2) production |
|
DCC4264 |
Protac_erralpha
Proteolysis targeting chimeras (PROTAC), providing broad tissue distribution and knockdown of the targeted ERRalpha protein in tumor xenografts |
|
DCC4265 |
Protac_ripk2
Proteolysis targeting chimeras (PROTAC), providing broad tissue distribution and knockdown of the targeted RIPK2 protein in tumor xenografts |
1801547-16-9 |
DCC4266 |
Protac-12
Novel SirReal-based PROTAC, inducing isotype-selective Sirt2 degradation, resulting in the hyperacetylation of the microtubule network coupled with enhanced process elongation |
|
DCC4267 |
Protac-3 (fak)
Novel selective and potent Fak degrader |
|
DCC4268 |
Protac-6c
The most potent and selective ERRα degrader |
|
DCC4269 |
Protac-i
Novel PROTAC, targeting steroid hormone receptors for ubiquitination and degradation |
1448189-04-5 |
DCC4270 |
Protegenin A
Novel bacterial polyyne contributing to the antioomycete and plant-protective effects of P. protegens |
|
DCC4271 |
Prs-211375
Novel selective CB2 agonist (CB2: 17.4 nM and CB1: 5585 nM) |
573981-31-4 |
DCC4272 |
Pr-snf
Novel potent and selective inhibitor of SETD2 |
|
DCC4273 |
Prucalopride Hydrochloride
Selective 5-HT4 agonist |
179474-80-7 |
DCC4274 |
Prx-07034
Novel selective 5-HT6 receptor antagonist, enhancing cognition and memory and potently decreasing food intake and body weight in rodents |
903580-39-2 |
DCC4275 |
Prx-08066 Maleate
Featured
Novel potent and selective 5-HT2B receptor antagonist |
866206-55-5 |
DCC4276 |
Ps1145 Dihydrochloride
Novel inhibitor of upstream IκB kinase (IKK), specifically inhibiting the IκB phosphorylation and degradation and the subsequent nuclear translocation of NF-κB |
1049743-58-9 |
DCC4277 |
Ps121912
Highly potent and selective VDR-coactivator inhibitor |
1529814-60-5 |
DCC4278 |
Psammaplysene B
Naturally occurring inhibitor of FOXO1a nuclear export |
865722-85-6 |
DCC4279 |
Psammaplysin F
Unique inhibitor of bacterial chromosomal partitioning, increasing the efficacy of bortezomib and sorafenib through regulation of stress granule formation |
|
DCC4280 |
Psb-1011
Potent competitive antagonist and positive modulator of the P2X2 receptor with >100-fold selectivity versus P2X4, P2X7, and several investigated P2Y receptor subtypes (P2Y(2,4,6,12)) |
4499-01-8 |
DCC4281 |
Psb-10129
Positive modulator of ATP effects at P2X2 receptors |
|
DCC4282 |
Psb-10211
Potent competitive antagonist and positive modulator of the P2X2 receptor |
66295-57-6 |
DCC4283 |
Psb-12105
Novel fluorescent-labeled selective adenosine A2B receptor antagonist |
|
DCC4284 |
Psb-1410
Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
1494477-03-0 |
DCC4285 |
Psb-1434
Featured
Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
1619884-65-9 |
DCC4286 |
Psb-1491
Featured
Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
1619884-67-1 |
DCC4287 |
Psb-16131
Novel potent Lp1NTPDase inhibitor |
1213268-80-4 |
DCC4288 |
Psb-16133
Novel Potent and Selective Antagonist for the UTP-Activated P2Y4 Receptor |
2089035-40-3 |
DCC4289 |
Psb-16282
Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 12 nM) |
|
DCC4290 |
Psb-16434
Novel potent and selective agonist of the orphan G protein-coupled receptor 84 (GPR84) |
|
DCC4291 |
Psb-18332
Fluorescent Probe for Ecto-5'--nucleotidase (CD73) |
|
DCC4292 |
Psb-18422
Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 27.9 nM) |
|
DCC4293 |
Psb-18484
Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 32.1 nM) |
|
DCC4294 |
Psb-19416
Fluorescent Probe for Ecto-5'--nucleotidase (CD73) |
|
DCC4295 |
Psb-6426
The first potent and selective inhibitor of human nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) |
958459-33-1 |
DCC4296 |
Psb-kd107
Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55 |
955121-65-0 |
DCC4297 |
Psb-kd477
Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55 |
|
DCC4298 |
psb-sb-1203
Potent GPR55 antagonist |
1399049-80-9 |
DCC4299 |
psb-sb-489
Novel Selective, competitive GPR55 antagonist |
1399049-86-5 |
DCC4300 |
Psma-1092
Novel Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection, Visualizing Tumors in Real Time |
|
DCC4301 |
Psma-sulfocy7
Novel PSMA ligand conjugated with fluorescent dye SulfoCy7, demonstrating good visualization of PSMA-expressing tumors and the absence of any explicit toxicity up to 87.9 mg/kg |
|
DCC4302 |
Pst2774 Oxalate
Na-K ATPase inhibitor, stimulating SERCA2a and accelerating calcium cycling in heart failure by relieving phospholamban inhibition |
203737-94-4 |
DCC4303 |
Ptc-12
Novel Bovine Viral Diarrhea (BVD) Inhibitor, specifically blocking BVDV cell entry |
|
DCC4304 |
Ptc-510 Tfa Salt
Novel inhibitor of hypoxia-induced VEGF expression |
865531-74-4 |
DCC4305 |
Pterophyllin 2
Natural antifungal agent, against postharvest fruit pathogenic fungi |
210231-09-7 |
DCC4306 |
Pti-ch
Novel CFTR modulator, increasing CFTR protein expression across different mutations, including F508del, by increasing CFTR mRNA levels by ~1.5 to ~2-fold in HBE cells |
|
DCC4307 |
Pti-cv
Novel CFTR modulator, binding to the poly-r(C) binding protein 1 (PCBP1), showing an affinity for RNA-bound PCBP1 higher than that of free PCBP1 |
|
DCC4308 |
Ptk6-in-21b
Novel Brk/PTK6 kinase inhibitor |
|
DCC4309 |
Ptk7/ß-catenin Inhibitor 01065
Novel Inhibitor of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer |
906147-24-8 |
DCC4310 |
Ptk7/ß-catenin Inhibitor 03653
Novel Inhibitor of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer |
|
DCC4311 |
Ptk-in-6a
Novel Potent Multi-target PTK Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) |
|
DCC4312 |
Ptk-sma1
Unique promoter of SMN2 exon 7 splicing, acting by directly stimulating splicing of exon 7 |
|
DCC4313 |
Pto-41
Novel NIR fluorescent probe for the detection of Aβ oligomers |
|
DCC4314 |
Ptp1b-in-18k
Novel non-competitive potent and selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) |
|
DCC4315 |
Ptpmt1-in-1
Novel PTEN-like mitochondrial phosphatase PTPMT1 inhibitor |
858746-75-5 |
DCC4316 |
Ptzmes2b
Novel thermally activated delayed fluorescence (TADF) molecule that exhibits high external quantum efficiency (EQE) in non-doped organic light-emitting diodes (OLEDs) at high luminescence |
|
DCC4317 |
Pu-20f
Hsp90α- and Hsp90ß-selective inhibitor |
422508-29-0 |
DCC4318 |
Pu24fcl
Novel specific inhibitor of tumor Hsp90 |
422508-46-1 |
DCC4319 |
Pu-29f
Hsp90α- and Hsp90ß-selective inhibitor |
422508-27-8 |
DCC4320 |
Pu-h39
Novel specific Hsp90b1 inhibitor |
852030-38-7 |
DCC4321 |
Pumafentrine
Dual inhibitor of PDE3 and PDE4 |
207993-12-2 |
DCC4322 |
Puupehenone
Natural heat shock protein 90 (Hsp90) inhibitor, potentiating the echinocandin drug caspofungin in caspofungin-resistant fungal pathogens, blocking the induction of caspofungin-responding genes required for the adaptation to cell wall stress through the c |
73573-17-8 |
DCC4323 |
Pu-ws13b
Novel Grp94-selective inhibitor PU-WS13 biotin probe |
1454619-21-6 |
DCC4324 |
Pv1019
Novel potent and selective CHEK2>Chk2 inhibitor |
1093793-05-5 |
DCC4325 |
Pvhd303
Novel potent anticancer agent, disturbing microtubule formation at the centrosomes and inhibiting the growth of tumors dose-dependently in the HCT116 human colon cancer xenograft model in vivo |
|
DCC4326 |
Pvhgprt Inhibitor
Novel Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitor |
|
DCC4327 |
Pw0564
Novel selective FGF14:Nav1.6 PPI modulator |
|
DCC4328 |
Pyclen
Inhibitor of cell death induced by oxidative stress and inhibitor of AB1-40 aggregation induced by Cu2+ ion |
78668-34-5 |
DCC4329 |
Pyimdc
Novel potent inhibitor of collagen prolyl-4-hydroxylases (CP4H) |
1821370-62-0 |
DCC4330 |
Py-itc
Novel suppressor of cancerous cell growth and proliferation |
36810-91-0 |
DCC4331 |
Pyochelin
Bacterial siderophore, acting as an iron-chelating growth promoter for Pseudomonas aeruginosa |
69772-54-9 |
DCC4332 |
pyranoxanthone 1
Novel inhibitor of p53-MDM2 interaction |
1241391-92-3 |
DCC4333 |
Pyrd-in-14
Novel inhibitor of the PyrD protein (a dihydroorotate dehydrogenase (DHODase) involved in pyrimidine biosynthesis), suppressing bacterial cytotoxicity, biofilm formation and antibiotic resistance |
|
DCC4334 |
Pyrenocine A
Natural phytotoxin, inducing monopolar spindle formation and suppressing proliferation of cancer cells |
76868-97-8 |
DCC4335 |
Pyridinone-14
Novel highly potent agonist of the apelin receptor (APJ) receptor (APJ cAMP EC50: human 0.023nM; rat 0.024nM; dog 0.030nM; monkey 0.080nM) |
|
DCC4336 |
Pyrithione Zinc
Novel KMD5A inhibitor |
1121-31-9 |
DCC4337 |
Pysoca Substrate-1
Novel BBB-permeable substrate of pyrilamine-sensitive proton-coupled organic cation antiporter (PYSOCA), acting as a selective class I HDAC inhibitor |
|
DCC4338 |
Pyy3-36
Y2/Y5 Neuropeptide Y receptor agonist, reducing food intake in normal-weight and obese individuals and the plasma levels of the hunger-promoting hormone ghrelin |
126339-09-1 |
DCC4339 |
Pz-1444
Novel inverse agonist of 5-HT6 receptor |
|
DCC4340 |
Q8pnap
Novel class of bright near infrared window II (NIR-II, 1,000 - 1,700 nm) probe, being successfully used to achieve high spatial and temporal resolution imaging of hind limb vasculature, lymphatic system, and small tumor metastasis, as well as precise NIR- |
|
DCC4341 |
q94 Hydrochloride
Selective PAR1 negative allosteric modulator |
1052076-77-3 |
DCC4342 |
Qc-308 Hydrochloride
Novel Heme Oxygenase-1 Inhibitor (HO-1 IC 50 =0.27μM; HO-2 IC 50 =0.46μM) |
1353586-18-1 |
DCC4343 |
Qd394-me
Novel reactive oxygen species (ROS) inducer, showing significant cytotoxicity in pancreatic cancer cells |
|
DCC4344 |
Qls-81
Novel Nav1.7 channel blocker (IC 50 at 3.5±1.5 μM). being efficacious on chronic pain in mice |
|
DCC4345 |
Qndesa
Novel fluorescent molecular rotor for the selective detection of the hybrid-conformation 22AG G-Quadruplex |
|
DCC4346 |
Qs Inhibitor 1
Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus |
887833-49-0 |
DCC4347 |
Qs Inhibitor 2
Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus |
1448066-54-3 |
DCC4348 |
Qtc-4-meobne
Novel multitarget anti-AD agent, significantly increasing in adult neurogenesis and remyelination through Prox1/NeuroD1 and Wnt/β-catenin pathways, demonstrating beneficial effects in preclinical models of AD |
|
DCC4349 |
Quatcy-i2
Novel photodynamic antitumor agent |
|
DCC4350 |
Quazepam
Modulator of specific GABAA receptors via the benzodiazepine site on the GABAA receptor |
36735-22-5 |
DCC4351 |
Quilseconazole Besylate
Potent, orally active fungal Cyp51 (lanosterol 14-α-demethylase) inhibitor |
1809323-18-9 |
DCC4352 |
Quinine Sulfate
Natural disrupter of DNA replication and transcription via DNA intercalation, reducing oxygen intake and carbohydrate metabolism and the excitability of muscle fibers, inhibiting the drug efflux pump P-glycoprotein |
804-63-7 |
DCC4353 |
Quoromycin
Novel antivirulence agent against Vibrio vulnificus, inhibiting the quorum-sensing signaling pathway by controlling the DNA-binding affinity of SmcR and thus effectively alleviating the virulence of V. vulnificus in vitro and in vivo |
205514-29-0 |
DCC4354 |
Qw-296
Novel microtubule destabilizer |
|
DCC4355 |
R-(+)-eu-1180-453
Second-Generation GluN2C- and GluN2D-selective positive allosteric modulator (PAM) of the N-methyl-d-aspartate (NMDA) receptor |
|
DCC4356 |
R(ccug) Ligand 63
Novel Potent and Specific Ligand of r(CCUG)exp, Targeting r(CCUG) Repeats in Myotonic Dystrophy Type 2, Facilitating Degradation by RNA Quality Control Pathways |
|
DCC4357 |
r-138329
Novel scavenger receptor class B type I blocker |
372095-04-0 |
DCC4358 |
r-154716
Novel inhibitor of HDL uptake induced by overexpression of scavenger receptor BI (SR-BI) |
939812-54-1 |
DCC4359 |
R523062
Novel Antiviral agent for Enterovirus D68 |
314768-41-7 |
DCC4360 |
r78206
Efficient stabilizer of Mahoney procapsids |
124436-97-1 |
DCC4361 |
R93274
Potent and selective antagonist of 5-HT2A receptors |
155928-24-8 |
DCC4362 |
Rac-azd8186
Novel inhibitor of PI3Kβ and PI3Kδ, inhibiting growth of PTEN deficient breast and prostate tumor |
1296270-45-5 |
DCC4363 |
Racemetirosine Methyl Ester Hcl
Prodrug of Racemetirosine, an inhibitor of tyrosine 3-monooxygenase |
1421-66-5 |
DCC4364 |
Rachelmycin
Novel potent DNA-alkylating agent, inhibiting TBP/DNA interaction |
69866-21-3 |